Ascletis Pharma Inc. (HKG:1672)
Hong Kong
· Delayed Price · Currency is HKD 6.18
-0.10 (-1.59%)
Apr 28, 2025, 4:08 PM HKT
Ascletis Pharma Revenue
In the year 2024, Ascletis Pharma had annual revenue of 1.28M CNY, down -97.73%. Ascletis Pharma had revenue of 1.28M in the half year ending December 31, 2024, a decrease of -91.92%.
Revenue
1.28M CNY
Revenue Growth
-97.73%
P/S Ratio
4,423.96
Revenue / Employee
5.55K CNY
Employees
231
Market Cap
6.04B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |